Effects of clonidine and IBMX on sulfobromophthalein disposition in rats

R. Agbaria, A. Hurwitz, Z. Ben-Zvi

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Clonidine, an α2-adrenoceptor agonist, inhibited the biliary excretion, reduced the plasma clearance and increased the hepatic retention of sulfobromophthalein (BSP) in a dose related fashion in rats. The maximal effects of clonidine on BSP disposition occurred about 4 h after pretreatment. The effects of clonidine on biliary excretion and hepatic retention of BSP were retained following laparotomy (with or without bile duct cannulation); however, the effect of clonidine on plasma disappearance profile was not retained following abdominal surgery. Isobutylmethylxanthine (IBMX) affected BSP disposition in a similar fashion as clonidine, in rats without bile duct cannulation only; no effect of IBMX could be observed in bile duct cannulation rats. Yohimbine, an α2-adrenoceptor antagonist, reversed the effects of clonidine, but not of IBMX, on BSP disposition. It thus seems that clonidine and IBMX exert their effects on BSP disposition by different mechanisms and probably at different sites.

Original languageEnglish
Pages (from-to)239-245
Number of pages7
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Issue number3
StatePublished - 1 Sep 1993


  • Clonidine
  • IBMX
  • biliary excretion
  • rat
  • sulfobromophthalein

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Effects of clonidine and IBMX on sulfobromophthalein disposition in rats'. Together they form a unique fingerprint.

Cite this